
Taigo Kato, MD, PhD, discusses the use of ctDNA-guided therapy in patients with RCC.
Taigo Kato, MD, PhD, is an assistant professor in the Department of Urology at Osaka University Graduate School of Medicine.

Taigo Kato, MD, PhD, discusses the use of ctDNA-guided therapy in patients with RCC.

Taigo Kato, MD, PhD, discusses future directions of MONSTAR-SCREEN-3 and how data from the study can be applied to clinical practice.

Taigo Kato, MD, PhD, discusses the background of the MONSTAR-SCREEN-3 in resectable RCC and the key findings from the study.